QQQ   414.51 (-2.10%)
AAPL   165.14 (-1.14%)
MSFT   399.39 (-1.21%)
META   481.55 (-4.04%)
GOOGL   154.02 (-1.28%)
AMZN   174.44 (-2.67%)
TSLA   147.17 (-1.84%)
NVDA   771.94 (-8.83%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.00 (+0.17%)
T   16.45 (+0.73%)
F   12.10 (+0.33%)
MU   106.73 (-4.65%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.20 (-0.20%)
AMC   3.19 (+9.25%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.75 (+1.04%)
QQQ   414.51 (-2.10%)
AAPL   165.14 (-1.14%)
MSFT   399.39 (-1.21%)
META   481.55 (-4.04%)
GOOGL   154.02 (-1.28%)
AMZN   174.44 (-2.67%)
TSLA   147.17 (-1.84%)
NVDA   771.94 (-8.83%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.00 (+0.17%)
T   16.45 (+0.73%)
F   12.10 (+0.33%)
MU   106.73 (-4.65%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.20 (-0.20%)
AMC   3.19 (+9.25%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.75 (+1.04%)
QQQ   414.51 (-2.10%)
AAPL   165.14 (-1.14%)
MSFT   399.39 (-1.21%)
META   481.55 (-4.04%)
GOOGL   154.02 (-1.28%)
AMZN   174.44 (-2.67%)
TSLA   147.17 (-1.84%)
NVDA   771.94 (-8.83%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.00 (+0.17%)
T   16.45 (+0.73%)
F   12.10 (+0.33%)
MU   106.73 (-4.65%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.20 (-0.20%)
AMC   3.19 (+9.25%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.75 (+1.04%)
QQQ   414.51 (-2.10%)
AAPL   165.14 (-1.14%)
MSFT   399.39 (-1.21%)
META   481.55 (-4.04%)
GOOGL   154.02 (-1.28%)
AMZN   174.44 (-2.67%)
TSLA   147.17 (-1.84%)
NVDA   771.94 (-8.83%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.00 (+0.17%)
T   16.45 (+0.73%)
F   12.10 (+0.33%)
MU   106.73 (-4.65%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.20 (-0.20%)
AMC   3.19 (+9.25%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.75 (+1.04%)
Free Trial
CVE:AQS

Aequus Pharmaceuticals (AQS) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free AQS Stock Alerts
C$0.02
-0.01 (-25.00%)
(As of 04/17/2024 05:33 PM ET)
Compare
Today's Range
C$0.02
▼
C$0.02
50-Day Range
C$0.01
▼
C$0.02
52-Week Range
C$0.01
▼
C$0.06
Volume
15,000 shs
Average Volume
124,794 shs
Market Capitalization
C$1.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsHeadlinesInsider Trades
AQS stock logo

About Aequus Pharmaceuticals Stock (CVE:AQS)

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

AQS Stock Price History

AQS Stock News Headlines

April 10, 2024 | americanbankingnews.com
Aequus Pharmaceuticals (CVE:AQS) Shares Up 33.3%
February 23, 2024 | theglobeandmail.com
Zoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 18, 2024 | theglobeandmail.com
Aequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)
December 12, 2023 | morningstar.com
Aequus Pharmaceuticals Inc AQS
November 30, 2023 | msn.com
Aequus Pharmaceuticals reports Q3 results
October 18, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc up on Thursday (AQS)
October 7, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc flat on Thursday (AQS)
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
October 5, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc flat on Tuesday (AQS)
September 29, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc flat on Friday (AQS)
September 29, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc flat on Wednesday (AQS)
August 30, 2023 | finanznachrichten.de
Aequus Pharmaceuticals: Aequus Reports Second Quarter 2023 Financial Highlights and General Update
August 29, 2023 | markets.businessinsider.com
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
August 25, 2023 | theglobeandmail.com
Closing Bell: Aequus Pharmaceuticals Inc up on Wednesday (AQS)
August 24, 2023 | finance.yahoo.com
Aequus Announces Zimed PF Now Available in Canada
August 22, 2023 | finance.yahoo.com
Aequus Announces Zimed PF Website Launch
August 18, 2023 | finance.yahoo.com
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada
July 6, 2023 | benzinga.com
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)
June 7, 2023 | ca.finance.yahoo.com
AQS.V - Aequus Pharmaceuticals Inc.
May 31, 2023 | finanznachrichten.de
Aequus Pharmaceuticals: Aequus Provides General Update and First Quarter 2023 Financial Highlights
May 31, 2023 | finance.yahoo.com
Aequus Provides General Update and First Quarter 2023 Financial Highlights
May 2, 2023 | finance.yahoo.com
Aequus Provides General Update and Fiscal 2022 Financial Results
April 19, 2023 | finance.yahoo.com
Aequus Grants Stock Options
April 5, 2023 | finance.yahoo.com
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update
March 26, 2023 | finance.yahoo.com
Aequus Pharmaceuticals Inc. (AQS.V)
December 20, 2022 | finance.yahoo.com
Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)
See More Headlines
Receive AQS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
6/04/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:AQS
CUSIP
N/A
CIK
N/A
Web
www.aequuspharma.ca
Phone
+1-604-3367906
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-3,270,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,569.60%
Return on Assets
-83.91%

Debt

Debt-to-Equity Ratio
138.88
Current Ratio
0.12
Quick Ratio
0.46

Sales & Book Value

Annual Sales
C$1.17 million
Price / Sales
1.70
Cash Flow
C$0.00 per share
Price / Cash Flow
5.00
Book Value
C($0.03) per share
Price / Book
-0.50

Miscellaneous

Outstanding Shares
132,630,000
Free Float
N/A
Market Cap
C$1.99 million
Optionable
Not Optionable
Beta
0.37
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Douglas Glen Janzen (Age 55)
    Chairman, CEO & President
    Comp: $206.25k
  • Ms. Ann Fehr CGA (Age 55)
    CPA, CFO & Corporate Secretary
    Comp: $136.13k
  • Mr. Grant Larsen
    Chief Commercial Officer

Key Competitors

View All Competitors

AQS Stock Analysis - Frequently Asked Questions

How have AQS shares performed in 2024?

Aequus Pharmaceuticals' stock was trading at C$0.03 on January 1st, 2024. Since then, AQS stock has decreased by 40.0% and is now trading at C$0.02.
View the best growth stocks for 2024 here.

When is Aequus Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our AQS earnings forecast.

What other stocks do shareholders of Aequus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aequus Pharmaceuticals investors own include GrowLife (PHOT), Unrivaled Brands (TRTC), Abbott Laboratories (ABT), Acorn Energy (ACFN), Crown Castle (CCI), Charlotte's Web (CWBHF), (FIRE.V) (FIRE), LiCo Energy Metals (LIC), Marijuana Company of America (MCOA) and Planet 13 (PLNHF).

How do I buy shares of Aequus Pharmaceuticals?

Shares of AQS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:AQS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press